annb0t
Top 20
Recce Pharmaceuticals
SYDNEY, Australia, March 29, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, is pleased to announce it has received a Research and Development (R&D) Tax Incentive rebate of A$3,084,955.19 from the Australian Tax Office for the year ending June 30, 2021.
The Australian Governmentâs 43.5% R&D Tax Incentive rebate backs Australian (domestic) Innovation, providing expand...
>>> Read more: Recce Pharmaceuticals Receives Research and Development (R&D) Incentive Rebate
SYDNEY, Australia, March 29, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, is pleased to announce it has received a Research and Development (R&D) Tax Incentive rebate of A$3,084,955.19 from the Australian Tax Office for the year ending June 30, 2021.
The Australian Governmentâs 43.5% R&D Tax Incentive rebate backs Australian (domestic) Innovation, providing expand...
>>> Read more: Recce Pharmaceuticals Receives Research and Development (R&D) Incentive Rebate
